Journal of Antimicrobial Chemotherapy (1999) 44, 319-327
© 1999 The British Society for Antimicrobial Chemotherapy
Review |
Pharmacokinetics of antibiotics in burn patients
Microbiology Department, Queen Mary's University Hospital, London, UK
Drug pharmacokinetics are significantly altered in the burned patient but the interplay of a large number of variables is involved in deciding how an individual will deal with a drug. Consequently the burn patient population shows significant inter- and intrapatient variation. In 1976 altered aminoglycoside pharmacokinetics and the need for increased dosage in burn patients was reported but, despite this early study, a review of the currently available literature shows that for many drugs there is a paucity of information to support current dosage recommendations. In addition, many reports are based upon small numbers of patients, and even in larger studies there is no standardization of the study population with regard to the important variables known to affect drug handling. For the sub-population of burn patients who eliminate drugs extremely rapidly, a concern exists over the adequacy of antibiotic dosing. It is suggested that antibiotic serum concentrations be measured for all drugs in every patient to ascertain whether there is a significant problem with dosing. Additionally, future pharmacokinetic studies need to be standardized in burn patients.
* Correspondence address. Consultant Microbiologist, PHLS, Coventry and Warwickshire Hospital, Stoney Stanton Road, Coventry CV1 4FH, UK. Tel: +44-01203-844121.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Gottschlich, J. Khoury, G. D. Warden, and R. J. Kagan An Evaluation of the Neuroendocrine Response to Sleep in Pediatric Burn Patients JPEN J Parenter Enteral Nutr, May 1, 2009; 33(3): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Lovering, R. Le Floch, L. Hovsepian, J. Stephanazzi, P. Bret, G. Birraux, and C. Vinsonneau Pharmacokinetic evaluation of linezolid in patients with major thermal injuries J. Antimicrob. Chemother., March 1, 2009; 63(3): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Dalley, J. Lipman, R. Deans, B. Venkatesh, M. Rudd, M. S. Roberts, and S. E. Cross Tissue Accumulation of Cephalothin in Burns: a Comparative Study by Microdialysis of Subcutaneous Interstitial Fluid Cephalothin Concentrations in Burn Patients and Healthy Volunteers Antimicrob. Agents Chemother., January 1, 2009; 53(1): 210 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Kiser, D. W. Hoody, M. D. Obritsch, C. O. Wegzyn, P. C. Bauling, and D. N. Fish Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Weinbren Pharmacokinetics of antibiotics in burns patients J. Antimicrob. Chemother., May 1, 2001; 47(5): 720 - 720. [Full Text] [PDF]
|
|
|
|
|
|
E. Sampol, A. Jacquet, M. Viggiano, V. Bernini, J.-C. Manelli, B. Lacarelle, and A. Durand Plasma, urine and skin pharmacokinetics of cefepime in burns patients J. Antimicrob. Chemother., August 1, 2000; 46(2): 315 - 317. [Abstract] [Full Text] [PDF]
|
|